CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-05 | Paul Robert Chief Medical Officer | Option exercise · Stock Option (right to buy) | −10,000 | 320,000 | ||
| 2020-02-04 | Oney Sabah Chief Business Officer | Option exercise | +16,667 | $8.16 | $136K | 610,585 |
| 2020-02-04 | Oney Sabah Chief Business Officer | Sale | −16,667 | $30.00 | $500K | 593,918 |
| 2020-02-04 | Oney Sabah Chief Business Officer | Option exercise · Stock Option (right to buy) | −16,667 | 100,000 | ||
| 2020-02-04 | SCHELLER RICHARD H Director | Sale | −10,000 | $29.67 | $297K | 9,981 |
| 2020-02-04 | Yu Calvin Vice President, Finance | Option exercise | +13,541 | $8.16 | $110K | 188,835 |
| 2020-02-04 | Yu Calvin Vice President, Finance | Sale | −63,541 | $30.04 | $1.9M | 125,294 |
| 2020-02-04 | Yu Calvin Vice President, Finance | Option exercise · Stock Option (right to buy) | −13,541 | 36,459 | ||
| 2020-02-03 | Wehner David M. Director | Purchase | +20,000 | $25.00 | $500K | 44,621 |
| 2020-01-30 | Paul Robert Chief Medical Officer | Option exercise | +8,000 | $8.16 | $65K | 281,719 |
| 2020-01-30 | Paul Robert Chief Medical Officer | Sale | −8,000 | $28.00 | $224K | 273,719 |
| 2020-01-30 | Paul Robert Chief Medical Officer | Option exercise · Stock Option (right to buy) | −8,000 | 330,000 | ||
| 2020-01-27 | Oney Sabah Chief Business Officer | Option exercise | +14,467 | $8.16 | $118K | 608,385 |
| 2020-01-27 | Oney Sabah Chief Business Officer | Sale | −14,467 | $25.05 | $362K | 593,918 |
| 2020-01-27 | Oney Sabah Chief Business Officer | Option exercise · Stock Option (right to buy) | −14,467 | 116,667 | ||
| 2020-01-23 | Oney Sabah Chief Business Officer | Option exercise | +2,200 | $8.16 | $18K | 596,118 |
| 2020-01-23 | Oney Sabah Chief Business Officer | Sale | −2,200 | $25.21 | $55K | 593,918 |
| 2020-01-23 | Oney Sabah Chief Business Officer | Option exercise · Stock Option (right to buy) | −2,200 | 131,134 | ||
| 2020-01-23 | Paul Robert Chief Medical Officer | Option exercise | +6,000 | $8.16 | $49K | 279,719 |
| 2020-01-23 | Paul Robert Chief Medical Officer | Sale | −5,401 | $24.22 | $131K | 274,318 |
Page 27 of 36 · 702 trades